Skip to main navigation Skip to search Skip to main content

Erratum: Therapeutic targeting of ATP7B in ovarian carcinoma (Clinical Cancer Research (2009) 15 (3770-3780) DOI: 10.1158/1078-0432.CCR-08-2306)

  • Lingegowda S. Mangala
  • , Vesna Zuzel
  • , Rosemarie Schmandt
  • , Erik S. Leshane
  • , Jyotsna B. Halder
  • , Guillermo N. Armaiz-Pena
  • , Whitney A. Spannuth
  • , Takemi Tanaka
  • , Mian M.K. Shahzad
  • , Yvonne G. Lin
  • , Alpa M. Nick
  • , Christopher G. Danes
  • , Jeong Won Lee
  • , Nicholas B. Jennings
  • , Pablo E. Vivas-Mejia
  • , Judith K. Wolf
  • , Robert L. Coleman
  • , Zahid H. Siddik
  • , Gabriel Lopez-Berestein
  • , Svetlana Lutsenko
  • Anil K. Sood

Research output: Contribution to journalComment/debate

Abstract

The editors are publishing this note to alert readers to a concern about this article (1): in Fig. 5A, the representative images for “empty liposome” and “control siRNA-DOPC” were both from the “empty liposome” group. MD Anderson’s Office of Research Oversight and Integrity evaluated this error and the original data from the authors; while the Office concluded it had no concerns regarding this publication, it recommended correction of the scientific record. The authors apologize for this error.

Original languageEnglish
Pages (from-to)4454
Number of pages1
JournalClinical Cancer Research
Volume27
Issue number15
DOIs
StatePublished - 1 Aug 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Erratum: Therapeutic targeting of ATP7B in ovarian carcinoma (Clinical Cancer Research (2009) 15 (3770-3780) DOI: 10.1158/1078-0432.CCR-08-2306)'. Together they form a unique fingerprint.

Cite this